Valneva’s chief medical officer said the company has capacity to send more doses if needed. Image credit: Shutterstock/mundissima. Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of efforts to curb […]
Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge Read More »
Figures show one in three adults in the UK are either deaf or experience hearing loss or tinnitus. Image credit: Shutterstock / Framesira. The world’s most recognisable earbuds just got an upgrade – a new hearing test and hearing aid
Apple’s hearing aid software is impressive, but audiologists still matter Read More »
Tuberculosis is the world’s deadliest infectious disease, responsible for the deaths of over one million people annually. Image credit: Shutterstock / Poetra.RH. Ahead of World Tuberculosis Day on 24 March, the World Health Organization (WHO) has said that cuts in
Global funding cuts reversing decades of tuberculosis progress, WHO says Read More »
Sanofi is increasing focus on innovative medicines while moving away from consumer health. Image credit: Shutterstock/Below the Sky. Sanofi is continuing its immunology pipeline push with an agreement to acquire Dren Bio’s bispecific antibody DR-0201 in a deal whose value
Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibody Read More »
Purdue sold the painkiller OxyContin (oxycodone) alongside aggressive marketing and misleading information. Image credit: Shutterstock / PureRadiancePhoto. Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners,
Sacklers to pay up to $7bn in Purdue Pharma’s opioid settlement plan Read More »
Curevo will use the funds for an extension of its Phase II programme to provide more dosing information for a Phase III trial. Image credit: Shutterstock / Stock Footage Inc. Curevo has set its sights on competing with GSK’s shingles
Curevo procures $110m and former-GSK exec for shingles vaccine candidate Read More »
There have been several high-profile deals between big pharma companies and ADC specialists in recent years. Image credit: Shutterstock/ afry_harvy. Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to $1.14bn, representing another big-dollar deal
Taiho outlays $1.14bn to acquire ADC specialist Araris Read More »
Dendritic cell therapies have shown promise in cancer treatment, but have not yet been approved by the EMA. Image credit: Shutterstock/ Juan Gaertner. The European Medicines Agency (EMA) has issued a warning about the dangers of unregulated advanced therapy medicinal
Unsafe and unregulated cell therapies being sold in Europe Read More »
The device, dubbed NPM-115, is a miniature sub-dermal implant that delivers exenatide, a glucagon-like peptide-1 receptor agonist (GLP-1RA). Image credit: Shutterstock / Formatoriginal. A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical
Vivani treats first patient with long-lasting drug implant for weight loss Read More »
There have recently been high-profile financial deals for lead-212-based drug candidates. Image credit: Shutterstock / Love Employee. Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based therapies. The company
Telix’s new lead-212 generator could dispel medical isotope scalability hurdles Read More »
